Collagenase II
(Synonyms: 胶原蛋白酶,Collagenase; Collagen hydrolase) 目录号 : GC19588Collagenase Ⅱ是一种基质金属蛋白酶(MMPs),用于组织分离,制备肝、骨、甲状腺、心脏和唾液腺细胞。
Cas No.:9001-12-1
Sample solution is provided at 25 µL, 10mM.
Collagenase Ⅱ is a matrix metalloproteinase (MMPs) used for tissue dissociation and the preparation of liver, bone, thyroid, heart, and salivary gland cells[1,2]. Collagenase can cleave the bond between neutral amino acids and glycine in the Pro-X-Glyc-Pro sequence, which is common in collagen [3]. The enzyme activity of collagenase requires the presence of divalent cations such as Ca2+ and Zn2+ for activation[4]. Collagenase activity is inhibited by agents such as ethylenediaminetetraacetic acid (EDTA), dithiothreitol (DTT), detergents, hexachlorocyclohexane, and heavy metal ions (Hg2+, Pb2+, Cd2+) [5]. Collagenase is relatively mild and exhibits good dissociation ability at physiological temperature and pH without the need for mechanical stirring or special equipment. The optimal pH for Collagenase II is 6.3-8.5, and its enzymatic activity is ≥125 CDU/mg solid (CDU = Collagen Digestion Units).
There are approximately five common types of collagenase [6]:
(1) Collagenase Type I (GC19589): Contains relatively uniform multiple enzymatic activities (including collagenase, caseinase, clostridiopeptidase, and trypsin activities), and is commonly used for the dissociation of epithelial, lung, adipose, and adrenal tissue cells.
(2) Collagenase Type II (GC19588): Contains higher clostridiopeptidase activity and is typically used for the dissociation of liver, bone, thyroid, heart, and salivary gland tissue cells.
(3) Collagenase Type III (GC19590): Contains lower protease activity and is commonly used for the dissociation of mammary gland cells.
(4) Collagenase Type IV (GC19591): Contains lower trypsin activity and is typically used for the preparation of islet cells or experiments that require the preservation of cell surface receptors.
(5) Collagenase Type V (GC19592): Partially purified, containing higher collagenase and caseinase activities, and is typically used for the dissociation of pancreatic islet tissue and connective tissue dissociation.
References:
[1] Sekhon B S. Matrix metalloproteinases–an overview[J]. Research and Reports in Biology, 2010: 1-20.
[2] Alipour H, Raz A, Zakeri S, et al. Therapeutic applications of collagenase (metalloproteases): A review[J]. Asian Pacific Journal of Tropical Biomedicine, 2016, 6(11): 975-981.
[3] Trabelsi O, Dumas V, Breysse E, et al. In vitro histomechanical effects of enzymatic degradation in carotid arteries during inflation tests with pulsatile loading[J]. Journal of the mechanical behavior of biomedical materials, 2020, 103: 103550.
[4] Eming S, Smola H, Hartmann B, et al. The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber[J]. Biomaterials, 2008, 29(19): 2932-2940.
[5] Daboor S M, Budge S M, Ghaly A E, et al. Extraction and purification of collagenase enzymes: a critical review[J]. Am. J. Biochem. Biotechnol, 2010, 6(4): 239-263.
[6] Alipour H, Raz A, Zakeri S, et al. Therapeutic applications of collagenase (metalloproteases): A review[J]. Asian Pacific Journal of Tropical Biomedicine, 2016, 6(11): 975-981.
本协议仅提供一个指导,请根据您的具体需要进行修改。
1. 溶液配制
(1)工作液:通常用HBSS平衡盐溶液(含Ca2+、Mg2+)制备成1-2 mg/mL的工作液。组织和细胞分散推荐使用工作浓度为0.5-2.5 mg/mL,软骨消化推荐使用工作浓度为1-2 mg/mL。
注意:未使用的溶液请分装保存在-20°C避光冷冻,使用前在冰上解冻,避免反复冻融。
2. 使用Collagenase Ⅱ进行组织分离方案:
(1)用无菌手术刀或剪刀将组织切成3-4 mm大小的组织块;
(2)用含 Ca2+、Mg2+ 的HBSS洗涤组织块数次;
(3)加入足量的含 Ca2+、Mg2+ 的HBSS浸没组织块,并加入Collagenase Ⅱ至需要工作浓度;
(4)于 37°C 孵育4-18 h。消化时使用水平摇床以及用3mM的CaCl2 补充消化可以提高消化效率;
(5)分散的细胞可以用网筛收集备用,未完全解离的组织可以用新鲜的Collagenase Ⅱ工作液在37℃进一步消化;
(6)用不含胶原酶的HBSS洗涤收集的细胞;
(7)用细胞培养基重悬上述细胞,接种到装有合适培养基的培养皿上。
3. 使用Collagenase Ⅱ获得大鼠滑膜细胞的方案[1](来自文献,仅供参考)
(1)取材:将大鼠的无菌滑膜组织置于冰上,用PBS冲洗3次以除去血液。将组织块在平皿中切成1mm3 小片。
(2)用0.15% 胰蛋白酶连续剥离3次,每次2min。将脱离的细胞悬液转移至装有血清的离心管中以停止脱离。
(3)加入0.08% Collagenase Ⅱ,37℃持续剥离30 min。
(4)分离液合并后过筛,将细胞悬液置于10mL离心管中,1000r/min离心5min。弃去上清液,用含10%胎牛血清(FBS)的杜尔伯科氏改良伊格尔培养基(DMEM)重悬细胞。
注意:以上实验方案为使用Collagenase Ⅱ进行组织分离提供指导。可以根据其他文献和具体实验要求进行调整。
References:
[1]Mao T, He C, Wu H, et al. RETRACTED ARTICLE: Silencing lncRNA HOTAIR declines synovial inflammation and synoviocyte proliferation and promotes synoviocyte apoptosis in osteoarthritis rats by inhibiting Wnt/β-catenin signaling pathway[J]. Cell Cycle, 2019, 18(22): 3189-3205.
Cas No. | 9001-12-1 | SDF | |
别名 | 胶原蛋白酶,Collagenase; Collagen hydrolase | ||
分子式 | 分子量 | ||
溶解度 | 储存条件 | Store at -20°C | |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Biological Activity: ≥125U/mg solid
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet